The Global Immunocytokines Market consists of cytokine-based therapeutics that are linked or fused with monoclonal antibodies or ligands. Immunocytokines help deliver cytokines specifically to tumors by binding cytokine moieties like interleukin-2 (IL-2), interleukin-12 (IL-12), and tumor necrosis factor (TNF) to targeting moieties. This targeted delivery reduces systemic toxicity and increases drug efficacy. Immunocytokines have emerged as promising anti-cancer agents due to their ability to stimulate the patient's immune system against tumor cells.
The Global Immunocytokines Market is estimated to be valued at US$ 697 Mn in 2024 and is expected to exhibit a CAGR of 41.% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the global immunocytokines are IOVance Biotherapeutics, Inc., Bluebird bio,Bellicum Pharmaceuticals, Inc.,Ionis Pharmaceuticals, Inc.,Juno Therapeutics, Inc. The key players are increasingly investing in research and development activities to develop more efficacious and targeted immunocytokines to expand their portfolio.
There is a growing demand for immunocytokines due to rising cancer prevalence across the world. According to WHO, cancer burden is expected to grow to 27.5 million new cases and 16.3 million cancer deaths by 2040. Immunocytokines offer targeted treatment options with less systematic toxicity.
Rising investments in research & development of advanced targeted immunotherapies has led to technological advancement in immunocytokine development. Next-generation immuno-oncology approaches like engineered cytokine receptors, immune checkpoints modulation, and chimeric antigen receptor T cell therapies are expanding the capabilities of immunocytokines.
Market Trends
Adoption of combination therapies- There is a growing trend of combining immunocytokines with other immunotherapies like checkpoint inhibitors, oncolytic viruses, cancer vaccines to achieve enhanced anti-tumor responses. This is expected to drive the immunocytokines market.
Focus on solid cancers- Major players are investing in clinical trials targeting solid cancers like melanoma, renal cell carcinoma, and pancreatic cancer in combination with other treatments. This will help immunocytokines penetrate newer oncology application areas.
Market Opportunities
Emerging economics- Developing countries in Asia Pacific and Latin America are expected to provide major opportunities owing to growing healthcare expenditure and increasing cancer incidence.
Next-gen molecular engineering- Further engineering of cytokines, ligands and targeting antibodies through molecular technologies may yield more efficacious immunocytokines with wider therapeutic windows. This can open new opportunities.
Impact Of COVID-19 On Global Immunocytokines Market Growth
The COVID-19 pandemic has significantly impacted the growth of the Global Immunocytokines Market. Several factors like lockdowns, restrictions on manufacturing and supply chain disruptions affected the market in the initial months of the pandemic. In the pre-COVID period, the market was growing at a steady pace owing to ongoing research and development activities in immuno-oncology. However, during the pandemic, clinical trials and new drug developments were halted or delayed. Research funding was also diverted to COVID-19 vaccine development. This negatively impacted the immunocytokines market growth in 2020 and 2021.
With vaccine rollout and easing of restrictions in 2022, the market is showing signs of revival. Manufacturers are resuming operations and clinical trials are restarting. The pandemic has also increased focus on immune-mediated therapies for cancer. This provides opportunities for immunocytokines to treat various cancers. Companies are investing more in R&D to develop safer and more effective immunocytokines. Governments across regions are supporting life science research with funding. The demand for immunotherapies is expected to rise in the post-COVID period as cancer treatments focus more on boosting patients' immune response. While short-term growth was impacted, immunocytokines are well-positioned to drive long-term market expansion.
Geographical Regions With Highest Immunocytokines Market Value
North America accounts for the largest share of the Global Immunocytokines Market in terms of value. This can be attributed to presence of major market players, rising cancer incidence and growing demand for personalized immunotherapies. The United States dominates the North American region due to robust research funding, approvals for novel immunotherapies and increasing adoption of immunocytokines in clinical settings.
Fastest Growing Region For Immunocytokines Market
Asia Pacific region is expected to witness the highest growth over the forecast period owing to rising healthcare investments, increasing disposable income, growing cancer burden and expanding biopharmaceutical industry. Presence of emerging economies like China and India providing low-cost manufacturing capabilities is supporting the development of novel immunotherapies including immunocytokines. Favorable government policies and initiatives are promoting life science R&D in the region.
Get more insights on this topic: https://www.trendingwebwire.com/global-immunocytokines-market-is-estimated-to-witness-high-growth-owing-to-advancements-in-cancer-immunotherapy/
Author Bio:
Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights. (LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )
What Are The Key Data Covered In This Global Immunocytokines Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Global Immunocytokines Market's growth between 2024 and 2031.
:- Accurate calculation of the size of the Global Immunocytokines Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Global Immunocytokines Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Global Immunocytokines Market vendors
FAQ’s
Q.1 What are the main factors influencing the Global Immunocytokines Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Global Immunocytokines Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Global Immunocytokines Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Comments
0 comment